Astorg Fund Analysis · Track Record 2026

Astorg is a leading European mid-market private equity firm, partner-owned since its 1998 spinoff from Suez Group, with approximately €23 billion of assets under management deployed across European and selectively US-headquartered businesses. The firm focuses on building lasting global leaders in B2B services, healthcare, technology and selected industrial niches through majority and significant minority equity investments, typically held for five to seven years across successive flagship fund vintages.

This Astorg fund analysis breaks down the firm's positioning, sector specialisation, recent 2024-2026 track record and how it compares with peers PAI Partners and Eurazeo, drawing on the live Astorg portfolio data on GP Intel and primary disclosures from Astorg investor relations and the Financial Times.

Astorg's positioning · partner-owned European mid-market specialist

Astorg was founded in 1998 as a spinoff from Suez Group, originally led by a senior management team that subsequently established the partner-owned independent ownership structure that persists today. Over 27 years of continuous investment activity, the firm has built one of the most experienced European mid-market private equity teams alongside a globalised footprint with offices in Paris (HQ), London, Luxembourg, Milan, Munich, New York and Frankfurt.

The partner-owned ownership structure aligns the senior team with limited partners across successive fund vintages, with carry distributions to senior partners supporting long-tenure partnership relationships. Astorg has maintained continuity in senior leadership across multiple fund vintages, with deep relationships with management teams in target sectors enabling repeat investments and successor businesses.

According to Astorg disclosures, the platform has deployed across 10 active fund vehicles spanning the flagship buyout strategy, complementary mid-cap fund, co-investment vehicle and selectively continuation-fund structures. The current fundraising momentum reflects sustained limited partner interest in the European mid-market buyout segment, with Astorg's track record positioning the firm as one of the structurally important names in continental European private equity.

Inside Astorg's investment strategy · B2B services, healthcare and tech focus

Astorg targets European mid-market and upper mid-market companies with €300 million to €2 billion enterprise value, deploying equity tickets between €150 million and €700 million per transaction. The strategy has progressively consolidated around four core verticals, with dedicated sector teams driving thematic origination and value creation.

B2B services is the largest vertical by deal count, including testing and inspection (Normec exit 2024), outsourced services, certification and compliance services and B2B software platforms. The vertical leverages Astorg's deep operational expertise in scaling pan-European service businesses through bolt-on M&A and geographic expansion.

Healthcare spans pharmaceutical services (clinical research organisations, Clario exit 2026), medical devices, contract development and manufacturing, and selective digital health platforms. Astorg has built dedicated sector team coverage with strong relationships across European healthcare management teams and intermediaries.

Technology includes enterprise software (Anaqua exit 2025 for IP management software, Acturis exit 2024 for insurance software), vertical SaaS and selectively digital infrastructure positions. The tech franchise has scaled significantly over the past decade as European mid-market software businesses have matured.

Selected industrials and other niches complement the core verticals with selective positions in industrial businesses with strong consolidation runway and value-creation potential through Astorg's operational improvement framework.

Astorg also operates complementary strategies: the Mid-Cap fund targets smaller European businesses with €150 million to €500 million enterprise value, while the Co-Investment vehicle allows institutional LPs to co-invest in selected platform deals. A continuation-fund capability allows the firm to extend ownership of high-conviction assets beyond traditional fund duration when value-creation runway warrants.

Astorg's track record · 2024-2026 exits

Asset rotation across the Astorg portfolio has been steady through 2024-2026, with realised exits demonstrating value creation across healthcare and software verticals.

Clario (healthcare, 2026) delivered a successful exit of the clinical trial endpoint technology platform in 2026, reflecting Astorg's healthcare vertical strength.

Anaqua (TMT/IP software, 2025) exited in 2025, demonstrating the platform's ability to back and realise European mid-market software businesses at scale.

Acturis (TMT/insurance software, 2024) completed in 2024, contributing to the technology franchise track record with another successful European software exit.

Normec (business services, 2024) completed in 2024 as part of the testing, inspection and certification consolidation wave, illustrating Astorg's B2B services platform strength.

Cumulatively, GP Intel tracks 44 realised Astorg exits across the firm's 27-year track record. Pro subscribers can access exit buyer identities, dates, sectors and disclosed financial parameters at €49 per month.

Where Astorg deploys capital · sectors and geographies

Astorg's portfolio composition reflects the firm's disciplined sector specialisation framework.

1. B2B services · the largest sector by deal count, including testing and inspection, outsourced services and B2B platforms.
2. Healthcare · pharma services, medical devices, contract research organisations and selective digital health.
3. TMT · enterprise software, vertical SaaS and selective digital infrastructure.
4. Industrials · selected industrial businesses with consolidation potential and operational improvement runway.

Geographically, deployment concentrates in Western Europe with selective exposure to North America. The seven-office international footprint supports both origination and value creation across pan-European platforms, with the New York office enabling selective US opportunities and limited partner servicing for North American institutional LPs.

Astorg vs PAI Partners vs Eurazeo · comparing France's mid-market buyout platforms

Three Paris-headquartered private markets firms compete in the European mid-large cap buyout segment: Astorg, PAI Partners and Eurazeo. The structural differences shape investor access and platform strategy mix.

Astorg (€23 billion AUM, partner-owned) focuses exclusively on European mid-large cap buyout with concentrated specialisation in B2B services, healthcare and technology. The disciplined sector focus enables deep vertical expertise and consistent senior team continuity across fund vintages.

PAI Partners (€33 billion AUM, partner-owned) targets similar European mid-large cap buyout with a broader sector mix including consumer, business services and industrials. PAI's larger AUM and consumer brand exposure (Froneri, Marcolin historically) distinguishes the firm from Astorg's tighter sector specialisation.

Eurazeo (€36.8 billion AUM, listed on Euronext Paris) operates a multi-strategy platform combining buyout, growth, secondaries, private debt and real assets through 31 active funds. The listed permanent capital structure and broader strategy mix differs structurally from Astorg's pure direct buyout focus.

The comparison table above summarises the headline data points, while detailed portfolio-level data is available on the Astorg, PAI Partners and Eurazeo fiches on GP Intel.

How Astorg's partnership structure shapes investment decisions

The partner-owned ownership structure since 1998 spinoff creates a distinctive culture and governance model. Senior partner alignment with limited partners through carry distributions and reinvestment commitments ensures consistent investment discipline across vintages. The lack of public listing provides operational flexibility for longer-duration positions when value-creation runway warrants and continuation-fund structures.

Astorg's sector team specialisation framework also influences capital allocation: dedicated B2B services, healthcare and technology teams drive thematic origination, with proprietary deal flow generated through deep relationships with sector management teams and intermediaries. This sector-specialist approach distinguishes Astorg from generalist mid-market firms and supports the consistency of returns across the platform's investment vintages.

According to Financial Times and industry publications, Astorg's combination of partner-owned governance, disciplined sector specialisation and consistent senior team continuity positions the firm as a structurally important name in European mid-market private equity, with the firm's track record in healthcare and software particularly noted across recent years.

How to track Astorg's deals in real time

For dealmakers, limited partners and analysts seeking ongoing visibility into Astorg's portfolio activity, GP Intel maintains a live tracking surface at /gp/astorg covering:

• 10 active fund vehicles with vintage, size and strategy classification
• 34 active portfolio companies with sector, geography and entry date
• 44 realised exits with buyer identity, year and sector (Pro tier)
• Multiple disclosures on selected exits including disclosed financial parameters (Pro tier)
• Recent activity feed across portfolio, exits and fundraising milestones

The data is hand-checked against Astorg's official disclosures, regulatory filings and industry publications. Free browsing covers full directory access; Pro access at €49 per month unlocks exit buyer identities, financial multiples, Excel exports and watchlist functionality for active diligence workflows.

For broader market context, the European PE landscape 2026 overview compares Astorg with the wider universe of European private markets firms, while the PAI Partners fund analysis and Eurazeo fund analysis provide peer comparison alongside the PE fund due diligence checklist for LPs assessing managers across the Paris-headquartered mid-market cluster.

Astorg's combination of partner-owned governance, disciplined sector specialisation in B2B services, healthcare and technology, and consistent senior team continuity positions the firm as a structurally distinctive name within European mid-market private equity. Whether tracking deployment pace, current portfolio composition or realised exit track record, the Astorg fiche on GP Intel remains the most current single source for live data on the firm.